Founded in 2015, Amiko is growing to become a global provider of digital medicines

About Amiko Digital Health Limited

Amiko has the ambition to offer a full range of technologies to collect data on delivery systems usage, including inhalers, nasal sprays, nebulizers, injectables, or pharmaceutical primary packaging. Our technology platforms are:

Proprietary and Patent Protected

Designed for add-on or integrated devices

Ideally suited for low-cost, low-power solutions

Amiko’s flagship product is Respiro®, a digital therapeutic solution that enables advanced tracking of respiratory medication use for improved adherence and treatment effectiveness.

Reply logo

Reply is a leading Consulting, Systems Integration and Digital Services company. Reply is listed on Borsa Italiana SpA since December 2000. In 2016, Reply recorded over $1 Billion in revenue.

Sanner logo

Sanner develops, manufactures, and markets plastic packaging and components for pharmaceutical, medical, and household products, with the knowhow of over 55 years on the market. In 2016, Sanner recorded over $100 Million in sales.

Our Awards

Corporate Headquarters

Salisbury House, 31 Finsbury Circus, London, UK

Amiko Italy

Via Washington, 105,
20144, Milan

Amiko Germany

Schillerstraße 80
D-64625 Bensheim